Robyn M. Emanuel

720 citations
7 papers · 140 indexed · h-index 5
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)Acute Myeloid Leukemia Research (2 papers)Cancer survivorship and care (2 papers)

In The Last Decade

Robyn M. Emanuel

7 papers receiving 137 citations

Peers

Robyn M. Emanuel
Comparison fields: 5 of 42
  • Genetics 63
  • Cognitive Neuroscience 48
  • Hematology 41
  • Psychiatry and Mental health 41
  • Molecular Biology 38
Replace John Irwin with:
John Irwin United States
Preben Bo Mortensen Denmark
Berenice Silva Argentina
Louise L. C. Pinto Brazil
Sirin Khajavian United States
Kristina Johnson United States
Claire Comerford Ireland
I. Khachikyan United States
Judith Gecht Germany
Robyn M. Emanuel relative to John Irwin United States John Irwin's profile →
Citations per field
00.5×10×13.7×
John Irwin · 1×
Citations per year

Countries citing papers authored by Robyn M. Emanuel

Since Specialization
Citations

This map shows the geographic impact of Robyn M. Emanuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn M. Emanuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn M. Emanuel more than expected).

Fields of papers citing papers by Robyn M. Emanuel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robyn M. Emanuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn M. Emanuel. The network helps show where Robyn M. Emanuel may publish in the future.

Co-authorship network of co-authors of Robyn M. Emanuel

This figure shows the co-authorship network connecting the top 25 collaborators of Robyn M. Emanuel. A scholar is included among the top collaborators of Robyn M. Emanuel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robyn M. Emanuel. Robyn M. Emanuel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 8
2 37
3 73
4 6
5 14
6 1
7 1

About Robyn M. Emanuel

Robyn M. Emanuel is a scholar working on Genetics, Hematology and Otorhinolaryngology, having authored 7 papers that have together received 140 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Genetics (63 citations), Hematology (41 citations) and Psychiatry and Mental health (41 citations). Robyn M. Emanuel has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Frederick Sierles, Cathy J. Lazarus, Kathleen Kashima, Ruben A. Mesa, Malin Hultcrantz, Björn Andréasson, Holly L. Geyer, Peter Johansson, Jan Samuelsson and Berit Johansson. Their work appears in journals such as Blood, Journal of General Internal Medicine and Leukemia & lymphoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026